Top 5 Safest Stocks To Own Right Now

tags:BABY,MNKD,VTA,REX,LQSIF,

Shutterstock

There’s no way around it: the S&P 500 now has a P/E ratio of more than 26 going into the first earnings season of 2017, and even the “safest” bets are starting to look scary.

Unless we see massive profit growth all around, there’s a real risk this bull market is going to stutter—or worse.

So where do you go for value? It’s getting harder than ever, but there is one corner of the market that got way ahead of the S&P 500 and has since taken a step back. I’m talking about real estate investment trusts (REITs).

And now, there are three REITs that combined provide over 9% in income with over 200% average dividend coverage. That means they could double their payouts and still generate enough cash to cover them.

Plus, these stocks are out of favor, making them relatively cheap compared to their peers and the overheated broader market.

Top 5 Safest Stocks To Own Right Now: Natus Medical Incorporated(BABY)

Advisors' Opinion:

• [By Motley Fool Transcription]

  Natus Medical Inc. (NASDAQ:BABY)Q4 2018 Earnings Conference CallFebruary 13, 2018, 11 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Brian Orelli]

  Shares of Natus Medical (NASDAQ:BABY) are up 12.4% as of 12:15 p.m. EDT following the release of the company's second-quarter earnings report. It wasn't exactly a blowout quarter for the hearing and neurology specialist, but given all the turmoil it has had lately (a proxy fight and its CEO retiring), investors appear to be excited about Natus clearing the bar and moving forward.

• [By Stephan Byrd]

  COPYRIGHT VIOLATION NOTICE: “Natus Medical Inc (BABY) Holdings Lifted by Los Angeles Capital Management & Equity Research Inc.” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this story can be read at https://www.tickerreport.com/banking-finance/4219997/natus-medical-inc-baby-holdings-lifted-by-los-angeles-capital-management-equity-research-inc.html.

• [By Joseph Griffin]

  BidaskClub downgraded shares of Natus Medical (NASDAQ:BABY) from a buy rating to a hold rating in a report released on Friday morning.

  Several other research firms also recently commented on BABY. Zacks Investment Research upgraded shares of Natus Medical from a sell rating to a hold rating in a research report on Friday, August 10th. ValuEngine upgraded shares of Natus Medical from a sell rating to a hold rating in a research report on Saturday, July 28th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The company has a consensus rating of Hold and a consensus target price of $44.33.

Top 5 Safest Stocks To Own Right Now: MannKind Corporation(MNKD)

Advisors' Opinion:

• [By Chris Lange]

  The number of MannKind Corp. (NASDAQ: MNKD) shares short decreased to 32.53 million. The previous reading was 35.96 million. The stock was last seen at $1.75, in a 52-week range of $1.01 to $6.96.

• [By Brian Feroldi]

  Here's are some of the biggest and best-know publicly traded diabetes companies:

  Company Ticker Market Cap Products  Abbott Laboratories (NYSE: ABT) $126 billion Continuous glucose monitor AstraZeneca (NYSE: AZN) $95 billion Pharmaceuticals Becton, Dickinson (NYSE: BDX) $70 billion Diagnostic and delivery devices DexCom (NASDAQ:DXCM) $12.7  billion Continuous glucose monitor Eli Lilly (NYSE: LLY) $106 billion Insulin and pharmaceuticals Insulet   (NASDAQ:PODD) $6.1 billion Insulin pump Johnson & Johnson (NYSE: JNJ) $375 billion  Glucose monitor and pharmaceuticals Lexicon Pharmaceuticals (NASDAQ: LXRX) $1.2 billion Pharmaceuticals MannKind (NASDAQ: MNKD) $291 million Inhaled insulin Medtronic (NYSE: MDT) $133  billion Insulin pumps and continuous glucose monitor Novo Nordisk (NYSE:NVO) $116 billion Insulin and pharmaceuticals Sanofi (NYSE: SNY) $108 billion Insulin and pharmaceuticals Senseonics Holdings (NYSEMKT: SENS) $834 million Continuous glucose monitor

  DATA SOURCE: YAHOO! FINANCE. MARKET CAP DATA AS OF 9/25/2018. 

• [By Brian Feroldi]

  Shares of MannKind Corporation (NASDAQ:MNKD) are soaring today, up 43% as of 9:35 a.m. EDT, following news that the company has struck up a collaborative partnership with United Therapeutics (NASDAQ:UTHR) that features a much-needed up-front payment. 

• [By Paul Ausick]

  Mannkind Corp. (NASDAQ: MNKD) traded down about 34% Friday to set a new 52-week low of $0.99. Shares closed at $1.50 on Thursday, and the 52-week high is $6.96. Volume was about five times the daily average of around 2 million. The struggling biopharma firm reported weak earnings last night.

• [By Motley Fool Transcribers]

  MannKind Corp  (NASDAQ:MNKD)Q4 2018 Earnings Conference CallFeb. 26, 2019, 9:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Chris Lange]

  The number of MannKind Corp. (NASDAQ: MNKD) shares short increased slightly to 35.96 million. The previous reading was 35.94 million. The stock was last seen at $1.73, in a 52-week range of $0.67 to $6.96.

Top 5 Safest Stocks To Own Right Now: Invesco Credit Opportunities Fund(VTA)

Advisors' Opinion:

• [By Joseph Griffin]

  Headlines about Invesco Dynamic Credit Opportunities Fd (NYSE:VTA) have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Invesco Dynamic Credit Opportunities Fd earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned press coverage about the investment management company an impact score of 46.2340823797619 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

• [By Joseph Griffin]

  Virtacoin (CURRENCY:VTA) traded flat against the US dollar during the twenty-four hour period ending at 16:00 PM ET on February 26th. Virtacoin has a total market capitalization of $6,049.00 and approximately $0.00 worth of Virtacoin was traded on exchanges in the last 24 hours. In the last week, Virtacoin has traded flat against the US dollar. One Virtacoin coin can currently be bought for approximately $0.0000 or 0.00000000 BTC on major exchanges.

• [By Joseph Griffin]

  Virtacoin (CURRENCY:VTA) traded flat against the dollar during the 24 hour period ending at 7:00 AM Eastern on March 13th. Over the last seven days, Virtacoin has traded 49.2% lower against the dollar. One Virtacoin coin can now be bought for $0.0000 or 0.00000000 BTC on cryptocurrency exchanges. Virtacoin has a market capitalization of $2,884.00 and $0.00 worth of Virtacoin was traded on exchanges in the last 24 hours.

• [By Max Byerly]

  Virtacoin (CURRENCY:VTA) traded down 11.7% against the U.S. dollar during the 24 hour period ending at 19:00 PM ET on September 25th. Virtacoin has a market capitalization of $26,710.00 and approximately $45.00 worth of Virtacoin was traded on exchanges in the last 24 hours. One Virtacoin coin can now be bought for $0.0000 or 0.00000000 BTC on major exchanges. Over the last seven days, Virtacoin has traded down 13.8% against the U.S. dollar.

Top 5 Safest Stocks To Own Right Now: REX American Resources Corporation(REX)

Advisors' Opinion:

• [By Ethan Ryder]

  imbrex (CURRENCY:REX) traded flat against the US dollar during the 24-hour period ending at 13:00 PM ET on September 30th. imbrex has a market cap of $459,204.00 and $10.00 worth of imbrex was traded on exchanges in the last 24 hours. In the last week, imbrex has traded 55.7% lower against the US dollar. One imbrex token can currently be purchased for $0.0530 or 0.00000802 BTC on major cryptocurrency exchanges including CoinExchange, IDEX and HitBTC.

• [By Stephan Byrd]

  LyondellBasell Industries (NYSE: LYB) and REX American Resources (NYSE:REX) are both basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, earnings, analyst recommendations and dividends.

• [By Max Byerly]

  imbrex (CURRENCY:REX) traded 35.7% higher against the U.S. dollar during the one day period ending at 23:00 PM Eastern on February 2nd. imbrex has a market cap of $243,929.00 and $30.00 worth of imbrex was traded on exchanges in the last 24 hours. In the last seven days, imbrex has traded 21.2% higher against the U.S. dollar. One imbrex token can now be purchased for $0.0282 or 0.00000807 BTC on cryptocurrency exchanges including IDEX, HitBTC and CoinExchange.

• [By Stephan Byrd]

  REX American Resources (NYSE:REX) will be issuing its quarterly earnings data before the market opens on Wednesday, May 23rd.

  REX American Resources (NYSE:REX) last released its earnings results on Thursday, March 22nd. The energy company reported $0.71 EPS for the quarter. The business had revenue of $109.54 million for the quarter. REX American Resources had a return on equity of 6.18% and a net margin of 8.77%.

Top 5 Safest Stocks To Own Right Now: Liquor Stores N.A. Ltd. (LQSIF)

Advisors' Opinion:

• [By ]

  British Columbia and Alberta have chosen a different strategy where retail sales will be allowed through both public and private stores, similar to its current setup for liquor retail in the provinces. Retailers will have to get their supply of cannabis from the government's wholesale distribution system, similar to how it works for alcohol now. The government will control online cannabis sales exclusively Our take: British Columbia also announced that physical retailing of cannabis and liquor will have to be separate, meaning stores cannot sell both products. This rule has an impact on existing liquor retailers aiming to convert some of their stores to sell cannabis. Aurora invested in Liquor Stores (renamed to Alcanna (OTCPK:LQSIF)) which has been struggling for years in the liquor business. Other pharmacy chains will also participate in the RFP as we have seen in Loblaw's recent win in Newfoundland and Labrador. We think for many cannabis companies the path to winning those retail licenses will be a challenging one with the competition from multiple sources. The licenses will be hotly contested given that B.C. is the largest market to allow private retailing, leaving us cautious on those companies betting big on winning those contracts. The likely outcome is that a large number of companies will each win fewer contracts.

• [By ]

  It also holds just under 20 percent share of Liquor Stores N.A. (OTCPK:LQSIF) and over 17 percent of Radient Technologies Inc. (OTC:RDDTF). Aurora has other holdings as well.